InvestorsHub Logo
Followers 28
Posts 4280
Boards Moderated 0
Alias Born 03/23/2016

Re: billpr post# 40233

Friday, 12/23/2016 5:11:13 PM

Friday, December 23, 2016 5:11:13 PM

Post# of 53784
If any of you regulars here get bored this weekend after eating Christmas dinner, take a serious look at CNAT. They are a tiny biotech developing a drug to help with liver disease. First look at their basic stats and realize the total number of outstanding shares is 26million, no debt, and now an even bigger pile of cash. Extremely low share count for a biotech.

If you are in to the details listen to some of the recent conf calls and presentations on the website. To date, the results are more than promising and Phase 2b and some 3s should start in Q2 and Q4 2017.

Then read the Novartis news from earlier this week and then start to do the math on those numbers and how they relate to 26million shares.

Then start scratching your head and come to the conclusion this thing could easily go up 5 to 10X within 12 months.....and still be too cheap.

I still love my VTSI and would never sell a share in order to buy something else, but some of you may be looking for ideas for the next year or two. Hopeful has some good posts on it on Investor Village. I know who Hopeful is and he is a smart and savvy man, a semi-retired accounting professor and author.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTSI News